Cargando…

Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: outcome and prognostic factors for patients who have never received hormonal therapy

OBJECTIVES: To evaluate the results of salvage conformal radiation therapy (3DC-EBRT) for patients submitted to radical prostatectomy (RP) who have achieved complete PSA response and who have never been treated with hormonal therapy (HT). To present the results of biochemical control, a period free...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacinto, Alexandre A, Fede, Angelo BS, Fagundes, Lívia A, Salvajoli, João V, Castilho, Marcus S, Viani, Gustavo A, Fogaroli, Ricardo C, Novaes, Paulo ERS, Pellizzon, Antonio Cássio A, Maia, Maria AC, Ferrigno, Robson
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1820601/ https://www.ncbi.nlm.nih.gov/pubmed/17316430 http://dx.doi.org/10.1186/1748-717X-2-8

Ejemplares similares

Preoperative external beam radiotherapy and reduced dose brachytherapy for carcinoma of the cervix: survival and pathological response
por: Jacinto, Alexandre A, et al.
Publicado: (2007)

Intensity Modulated Radiotherapy (IMRT) in the postoperative treatment of an adenocarcinoma of the endometrium complicated by a pelvic kidney
por: Castilho, Marcus S, et al.
Publicado: (2006)

Chemotherapy followed by low dose radiotherapy in childhood Hodgkin's disease: retrospective analysis of results and prognostic factors
por: Viani, Gustavo A, et al.
Publicado: (2006)

Whole brain radiation therapy in management of brain metastasis: results and prognostic factors
por: Saito, Elisa Y, et al.
Publicado: (2006)

Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems
por: Viani, Gustavo A, et al.
Publicado: (2007)

The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition
por: Pellizzon, Antonio Cassio Assis, et al.
Publicado: (2008)

High-dose-rate brachytherapy for soft tissue sarcoma in children: a single institution experience
por: Viani, Gustavo A, et al.
Publicado: (2008)

Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy
por: Pellizzon, Antonio Cassio Assis, et al.
Publicado: (2006)

High-risk surgical stage 1 endometrial cancer: analysis of treatment outcome
por: Viani, Gustavo A, et al.
Publicado: (2006)

Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience
por: Quero, Laurent, et al.
Publicado: (2008)

Salvage high-dose-rate interstitial brachytherapy for locally recurrent rectal cancer
por: Pellizzon, Antônio Cássio Assis
Publicado: (2016)

The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy
por: Ishikawa, Hitoshi, et al.
Publicado: (2020)

Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience
por: Murgic, Jure, et al.
Publicado: (2021)

Salvage robotic radical prostatectomy
por: Kaffenberger, Samuel D., et al.
Publicado: (2014)

What is the possible role of PSA doubling time (PSADT) and PSA velocity (PSAV) in the decision-making process to initiate salvage radiotherapy following radical prostatectomy in patients with prostate cancer?
por: Milecki, Piotr, et al.
Publicado: (2011)

Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
por: Wang, Yu-Jen, et al.
Publicado: (2016)

Salvage Post-Operative Stereotatic Ablative Radiotherapy for Re-Current Squamous Cell Carcinoma of Head and Neck
por: Pellizzon, Antonio, et al.
Publicado: (2022)

Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
por: Viani, Gustavo Arruda, et al.
Publicado: (2019)

Prognostic significance of a novel indicator (PSA(postd3)/PSA(pre)) for PSA recurrence in patients after radical prostatectomy
por: Zhou, Zhien, et al.
Publicado: (2019)

Impact of (68)Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy
por: Bluemel, Christina, et al.
Publicado: (2016)

Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study
por: Mizowaki, Takashi, et al.
Publicado: (2015)

The natural history of a delayed detectable PSA after radical prostatectomy
por: Szymaniak, Julie A., et al.
Publicado: (2023)

High-dose-rate brachytherapy using Leipzig applicators for non-melanoma localized skin cancer
por: Pellizzon, Antonio Cassio Assis, et al.
Publicado: (2020)

Introduction of salvage prostatectomy in Denmark: the initial experience
por: Mortensen, Mike Allan, et al.
Publicado: (2022)

PSA mass as a marker of prostate cancer progression after radical prostatectomy
por: Bryniarski, Piotr, et al.
Publicado: (2011)

Heterophilic Antibodies Resulting in False Positive Elevation of PSA After Radical Prostatectomy
por: Asha, Wafa, et al.
Publicado: (2023)

Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival
por: Doherty, A P, et al.
Publicado: (2000)

Three Months’ PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy—STARR (NCT05455736)
por: Francolini, Giulio, et al.
Publicado: (2023)

Technical caveats in salvage robot assisted radical prostatectomy
por: Tamhankar, Ashwin, et al.
Publicado: (2020)

Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy
por: Preisser, Felix, et al.
Publicado: (2023)

Never say never…
por: Schmidt, Laura A.
Publicado: (2021)

Enhanced electrogastrography: A realistic way to salvage a promise that was never kept?
por: Poscente, Michael D, et al.
Publicado: (2017)

[−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report
por: De Luca, S., et al.
Publicado: (2016)

Robotic-assisted vs. open radical prostatectomy: an update to the never-ending debate
por: Chandrasekar, Thenappan, et al.
Publicado: (2018)

Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes
por: Kwon, Ohseong, et al.
Publicado: (2014)

Robotic Salvage Lymph Node Dissection After Radical Prostatectomy
por: Torricelli, Fabio C. M., et al.
Publicado: (2015)

Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy
por: Zaine, Hind, et al.
Publicado: (2021)

Comparing open and robotic salvage radical prostatectomy after radiotherapy: predictors and outcomes
por: Martinez, Pablo F., et al.
Publicado: (2021)

Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer
por: Bravi, Carlo A., et al.
Publicado: (2022)

Temperature Control of psaA Expression by PsaE and PsaF in Yersinia pestis
por: Quinn, Joshua D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r8nndpc0pu4ut4fs41vpv70uvs